ORTHO EVRA

LOE Approaching

ethinyl estradiol; norelgestromin

NDATRANSDERMALFILM, EXTENDED RELEASE
Approved
Nov 2001
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
6

Clinical Trials (5)

NCT01535820Phase 1Completed

The Effect of an Adhesive Overlay on the Delivery of Contraceptive Hormones From ORTHO EVRA® in Healthy Women

Started Mar 2011
54 enrolled
Healthy Volunteers
NCT00511784N/ACompleted

Relative Risks for Non-fatal Venous Thromboembolism, Ischemic Stroke and Myocardial Infarction in Users of ORTHO EVRA(Norelgestromin and Ethinyl Estradiol Contraceptive Patch) Compared to Levonorgestrel-containing Oral Contraceptives.

Started Nov 2006
440 enrolled
ContraceptionFemale ContraceptionFertility Control
NCT00258076Phase 1Completed

A Study to Evaluate the Hormone Exposure From Multiple Commercial Lots of ORTHO EVRA (a Transdermal Contraceptive Patch)

Started Apr 2004
53 enrolled
ContraceptionFemale Contraception
NCT00254865Phase 1Completed

A Comparative Pharmacokinetic Study of ORTHO EVRA (a Transdermal Contraceptive Patch) and CILEST (an Oral Contraceptive) in Healthy Female Volunteers

Started Aug 2002
34 enrolled
ContraceptionFemale Contraception
NCT00331071N/ACompleted

Postmarketing Study of ORTHO EVRA (Norelgestromin and Ethinyl Estradiol Contraceptive Patch) in Relation to Venous Thromboembolism (Blood Clots), Stroke and Heart Attacks

Started Apr 2002
334 enrolled
ContraceptionFemale Contraception